CDX-301
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for CDX-301, covering 2017-04-07 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma [Phase 1]